Scarica l'app Stockscreener
80.08
1.72%
1.2348
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$78.85
Aprire:
$80.06
Volume 24 ore:
1.09M
Relative Volume:
0.80
Capitalizzazione di mercato:
$9.13B
Reddito:
$13.38B
Utile/perdita netta:
$418.00M
Rapporto P/E:
24.19
EPS:
3.3112
Flusso di cassa netto:
$391.00M
1 W Prestazione:
+5.12%
1M Prestazione:
+16.26%
6M Prestazione:
+5.21%
1 anno Prestazione:
+12.75%
Intervallo 1D:
$78.79
$80.51
Intervallo di 1 settimana:
$76.13
$81.21
Portata 52W:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
80.11 | 8.98B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
791.28 | 95.01B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
282.43 | 54.72B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
222.80 | 50.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.37 | 1.19B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-16 | Iniziato | BTIG Research | Neutral |
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-02-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Henry Schein (HSIC) Upgraded to Buy with $100 Price Target - GuruFocus
BTIG Upgrades Henry Schein to Buy From Neutral, Price Target is $100 - marketscreener.com
BTIG upgrades Henry Schein stock rating on strong dental growth - Investing.com
BTIG upgrades Henry Schein stock rating on strong dental growth By Investing.com - Investing.com Canada
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Henry Schein stock: Is Wall Street bullish or bearish? - MSN
Henry Schein Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Henry Schein, Inc. $HSIC Shares Sold by Lyrical Asset Management LP - MarketBeat
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Healthcare Distribution with a 12.61% Upside - DirectorsTalk Interviews
Fiduciary Management Inc. WI Decreases Stock Position in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein, Inc. $HSIC Holdings Lowered by Nuance Investments LLC - MarketBeat
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report? - Yahoo Finance
Henry Schein sees steady dental demand, $125M profit lift by 2026 - MSN
Henry Schein (HSIC) Q1 2026 Earnings Transcript - AOL.com
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring A 13.89% Potential Upside - DirectorsTalk Interviews
How Henry Schein’s New Chairman and Governance Shift At Henry Schein (HSIC) Has Changed Its Investment Story - simplywall.st
Henry Schein Q1 2026 earnings preview - MSN
Henry Schein Assures 2026 Financial Goals Amid Steady Dental Demand - HarianBasis.co
Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026 - TradingView
Here's why Henry Schein (HSIC) is a strong momentum stock - MSN
Henry Schein (NASDAQ: HSIC) SVP files Form 3 on share and option holdings - Stock Titan
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock - Yahoo Finance
Is This the Right Time to Keep HSIC Stock in Your Portfolio? - TradingView
Dental giant Henry Schein announces new independent chairman of the board - Dental Tribune US
Henry Schein (HSIC) ex-director corrects date on 50-share stock gift - Stock Titan
Henry Schein stock (US42548G1040): Dental and medical distributor navigates shifting US healthcare d - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Healthcare Distributor with 17.52% Potential Upside - DirectorsTalk Interviews
Henry Schein highlights dental momentum, $125M savings goal despite medical softness - MSN
Henry Schein Names New Independent Chairman Amid Governance Shift - The Globe and Mail
Henry Schein appoints William Daniel as independent chairman - Investing.com UK
Henry Schein (HSIC) director reports bona fide 50-share stock gift - Stock Titan
Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board, Succeeding Stan Bergman After 44 Years - Minichart
Henry Schein appoints William Daniel as independent chairman By Investing.com - Investing.com South Africa
Henry Schein, Inc. (HSIC) Announces Key Decisions from 2026 Annu - GuruFocus
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Henry Schein Names William K. Daniel as Independent Chairman - Moomoo
Henry Schein Names New Board Chairman - Dentistry Today
Henry Schein announces the election of William K. "Dan" Daniel as independent chairman of the board - marketscreener.com
Dan Daniel becomes Henry Schein (HSIC) independent chair as Bergman retires - Stock Titan
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board - Business Wire
Henry Schein Governance Push Meets Discounted Valuation And Mixed Share Performance - Sahm
Henry Schein (HSIC) director Stanley Bergman gifts 1,040 shares - Stock Titan
Henry Schein stock (US42548G1040): Q1 2026 results and outlook update put margins in the spotlight - AD HOC NEWS
Assessing Henry Schein (HSIC) Valuation After Recent Uneven Share Price Performance - Yahoo Finance
Henry Schein Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Henry Schein stock (US42548G1040): Q1 results and outlook update draw investor focus - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution - DirectorsTalk Interviews
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness - MarketBeat
A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance - Sahm
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
3.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):